The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell Carcinoma
Clinical trial NCT05831930 · UNKNOWN
Trial details
- NCT number
- NCT05831930
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-17
- Primary completion
- 2026-01-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.